CION Ameerpet
A pilocytic astrocytoma is the most common brain tumour in children — usually benign, slow-growing, and often curable with surgery. This guide explains what it means for your child and how CION's paediatric team walks the journey with you.
A pilocytic astrocytoma is a slow-growing brain tumour that starts in the astrocytes — the star-shaped support cells of the brain. It is graded WHO grade 1, the lowest and most favourable grade, and is a type of astrocytoma. It is the most common brain tumour in children and is often called a juvenile pilocytic astrocytoma.
Because it grows slowly, has clear borders, and rarely spreads, it behaves very differently from aggressive tumours. In many children — especially when the tumour is in the cerebellum — surgery to remove it can be curative on its own. Learning that your child has a brain tumour is frightening; the reassuring part of this particular diagnosis is that grade 1 pilocytic astrocytomas have one of the most hopeful outlooks of any brain tumour.
This page is a concise, family-focused guide. Childhood brain tumours, including this one, are cared for under CION's Pediatric Cancer team — see our overview of childhood brain tumours and our brain tumour treatment page for the wider picture.
Pilocytic astrocytoma is a WHO grade 1 tumour — the most favourable grade — and is the most common central-nervous-system tumour in children and adolescents. Per the WHO CNS classification and children's neuro-oncology guidance referenced by NCCN, most pilocytic astrocytomas carry a change in the BRAF gene, which helps confirm the diagnosis and can be targeted with medicine when the tumour cannot be completely removed by surgery. (Source: WHO CNS classification; NCCN and paediatric neuro-oncology guidelines.)
Brain tumours are graded, not staged. The grade describes how the cells look and how fast they grow. A grade 1 pilocytic astrocytoma sits at the gentlest end of that scale.
Unlike diffuse gliomas that spread through normal brain, a pilocytic astrocytoma has clear edges and grows slowly. That is exactly why a neurosurgeon can often remove it completely, and why the outlook is generally so good.
Grade 1 pilocytic astrocytomas are generally benign (non-cancerous) and rarely change into a higher grade. "Benign" does not mean "ignore it" — depending on location it can press on nearby structures, so it still needs proper treatment.
Most commonly in the cerebellum (which controls balance), along the optic pathway, or near the brainstem. The location shapes both the symptoms and how completely the tumour can be safely removed.
Pilocytic astrocytoma is entirely different from high-grade tumours such as glioblastoma. Sharing the word "astrocytoma" can be alarming — but the grade 1 form is far more favourable. Getting the exact diagnosis on tissue is what confirms this.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether you have just received the diagnosis, want to understand the surgery and the outlook, or need a second opinion, CION's paediatric neuro-oncology team is here to walk this journey with you.
Because the tumour grows slowly, symptoms often build up gradually and can be easy to miss at first. What a child notices depends on where the tumour sits. Common signs include:
Most of these symptoms have ordinary, non-tumour causes and are not a brain tumour. But a symptom that is new, persistent and steadily worsening should always be checked by a doctor, and a brain MRI arranged if needed. For a fuller guide, see brain tumour symptoms in children. Speak to a CION paediatric neuro-oncologist if you are worried or have a confirmed diagnosis.
Confirming a pilocytic astrocytoma — and pinning down its exact type — follows a careful, step-by-step pathway. CION delivers the imaging, biopsy coordination, molecular testing and expert review directly.
MRI is the gold standard for finding and characterising the tumour. With gadolinium contrast, it shows the tumour's location, size and edges — and pilocytic astrocytomas often have a fairly typical appearance that suggests the diagnosis. See MRI for a brain tumour for how the scan is used.
Imaging can strongly suggest a pilocytic astrocytoma, but a tissue sample confirms the exact type and grade. Tissue is usually obtained during surgery to remove the tumour, or occasionally through a stereotactic biopsy — the surgical steps coordinated with accredited neurosurgical partners.
Most pilocytic astrocytomas carry a change in the BRAF gene. Testing for it on the tissue sample helps confirm the diagnosis and, importantly, opens up targeted therapy options if the tumour cannot be fully removed. NCCN and paediatric neuro-oncology guidance support molecular testing to guide treatment. CION arranges BRAF testing as standard on pilocytic astrocytoma tissue.
For a pilocytic astrocytoma, how much of the tumour is safely removed is one of the biggest factors in the outcome. When a cerebellar pilocytic astrocytoma is completely removed, surgery alone is often curative and no radiation or chemotherapy is needed. When the tumour sits in a delicate area (such as the optic pathway) and cannot be fully removed, careful monitoring, chemotherapy, or targeted therapy against a BRAF change are used instead of rushing to more aggressive treatment. (Source: NCCN and paediatric neuro-oncology guidelines.)
In children, care is delivered under CION's Pediatric Cancer team, and every child's plan is reviewed by a multidisciplinary tumour board. The plan depends on the tumour's location, how completely it can be removed, and your child's age. The main building blocks are:
The first and most important step is maximal safe removal of the tumour, coordinated with accredited neurosurgical partners. For a cerebellar pilocytic astrocytoma, complete removal is often achievable and can be curative on its own, with no further treatment needed beyond follow-up scans.
If a small amount of tumour remains, or the tumour is stable and not causing problems, the team may recommend careful monitoring with regular surveillance MRI rather than immediate further treatment — sparing a child the side effects of therapy while the tumour is quiet.
When a tumour cannot be fully removed and is growing or causing symptoms, chemotherapy or targeted therapy against a BRAF alteration may be used. CION's oncology team delivers systemic therapy directly, with the specific drug choice guided by molecular testing and children's neuro-oncology guidelines.
Radiation is generally avoided in young children where possible, to protect the developing brain. In selected older children with tumours that cannot be controlled by surgery or medicine, precise radiation therapy may be discussed as part of coordinated specialist care. CION delivers radiation (IMRT/IGRT) directly.
The outlook for a child with a pilocytic astrocytoma is generally very favourable, particularly when the tumour is fully removed. Published data from sources such as SEER and children's oncology groups report high long-term survival for grade 1 pilocytic astrocytoma — often well above 90% at 5 and 10 years. These are ranges from published studies, not guarantees, and the exact outlook depends on the tumour's location and how much can be safely removed. Every child is different.
Long-term follow-up with surveillance MRI matters, because a tumour that could not be fully removed can slowly regrow and may need further treatment. A second opinion is especially worthwhile in a few situations:
CION offers a dedicated, free written second-opinion service and family-centred care. You deserve a plan built around your child's healing, not billing — with transparent costs explained up front. Learn more on our Pediatric Cancer hub, request your free second opinion, or call 18002028726.
Get a free written second opinion from CION's paediatric neuro-oncology tumour board — especially helpful before surgery, or if BRAF molecular testing has not yet been arranged.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.A pilocytic astrocytoma is a slow-growing brain tumour that begins in the astrocytes, the star-shaped support cells of the brain. It is classed as a WHO grade 1 (low-grade) astrocytoma — the least aggressive grade — and is a type of astrocytoma. It is the most common brain tumour in children and is also called juvenile pilocytic astrocytoma. Because it grows slowly and usually has well-defined edges, it rarely spreads and is often curable with surgery alone. It most often develops in the cerebellum (which controls balance), the optic pathway, or near the brainstem. It can occasionally appear in young adults.
A grade 1 pilocytic astrocytoma is generally considered benign (non-cancerous). It is slow-growing, has clear borders, and rarely invades deeply into surrounding brain or spreads elsewhere. That said, "benign" does not mean "harmless" — depending on where it sits, it can press on important structures and cause symptoms, so it still needs proper assessment and treatment. Malignant transformation to a higher grade is very rare in a typical grade 1 pilocytic astrocytoma. The exact diagnosis is confirmed by a pathologist examining tissue, not by a scan alone, which is why molecular testing and expert review matter.
Pilocytic astrocytoma is a grade 1 astrocytoma — the lowest, most favourable grade on the WHO scale of 1 to 4. Unlike diffuse (grade 2) astrocytomas that infiltrate normal brain, or aggressive high-grade gliomas such as glioblastoma, a pilocytic astrocytoma is well-circumscribed and slow-growing. Many carry a change in the BRAF gene, which is used to confirm the diagnosis and can guide targeted therapy if the tumour cannot be fully removed. This favourable biology is why the outlook for a child with a fully removed pilocytic astrocytoma is generally very good.
The main treatment is surgery to remove the tumour, coordinated with accredited neurosurgical partners. When the tumour is completely removed — which is often possible with cerebellar tumours — surgery alone can be curative and no further treatment is needed. If the tumour is in a hard-to-reach area (such as the optic pathway or deep midline) and cannot be fully removed, options include close monitoring, chemotherapy, targeted therapy against a BRAF change, or precise radiation therapy in selected older children. In children, treatment is delivered under CION's Pediatric Cancer team, following NCCN and children's neuro-oncology guidance, with every case reviewed by a multidisciplinary tumour board.
The outlook is generally very favourable, especially when the tumour can be completely removed. Published data from sources such as SEER and children's oncology groups report high long-term survival for grade 1 pilocytic astrocytoma — often well above 90% at 5 and 10 years — though the exact figure depends on the tumour's location, how much can be safely removed, and the individual child. These numbers are ranges from published studies, not guarantees, and every child is different. Long-term follow-up with surveillance MRI is important, because a tumour that could not be fully removed can slowly regrow and may need further treatment.
Because it grows slowly, symptoms often build up gradually. In children, common signs relate to raised pressure inside the head or to the tumour's location: morning headaches, repeated vomiting (especially in the morning), unsteadiness or clumsiness, and problems with balance or coordination if it is in the cerebellum. Optic-pathway tumours can cause vision changes or squint. In babies, an unusually fast-growing head size can be a clue. Most of these symptoms have ordinary, non-tumour causes — but any symptom that is new, persistent and steadily worsening should be assessed by a doctor and, if needed, a brain MRI. See brain tumour symptoms in children for more.
Childhood brain tumours, including pilocytic astrocytoma, are managed under CION's Pediatric Cancer service, which brings together paediatric oncology, radiation oncology, imaging and molecular testing, with surgery coordinated through accredited neurosurgical partners. CION delivers systemic (drug) therapy, radiation therapy, molecular testing, and supportive care directly, and every child's plan is reviewed by a multidisciplinary tumour board. You can also read our overview of childhood brain tumours. Care is family-centred, with a 45-minute consultation, transparent costs, and a free written second opinion available.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.